pIRESneo-FLAG/HA Ago2 Citations (4)

Originally described in: Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.
Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T Mol Cell. 2004 Jul 23. 15(2):185-97. PubMed Journal

---

Articles Citing pIRESneo-FLAG/HA Ago2

Articles
Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells. Noman MZ, Buart S, Romero P, Ketari S, Janji B, Mari B, Mami-Chouaib F, Chouaib S. Cancer Res. 2012 Sep 15;72(18):4629-41. Epub 2012 Sep 7. PubMed
Oligodendroglial Argonaute protein Ago2 associates with molecules of the Mbp mRNA localization machinery and is a downstream target of Fyn kinase. Muller C, Schafer I, Luhmann HJ, White R. Front Cell Neurosci. 2015 Aug 25;9:328. doi: 10.3389/fncel.2015.00328. eCollection 2015. PubMed
Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation. Conger AK, Martin EC, Yan TJ, Rhodes LV, Hoang VT, La J, Anbalagan M, Burks HE, Rowan BG, Nephew KP, Collins-Burow BM, Burow ME. Noncoding RNA. 2016 Sep 21;2(3). pii: ncrna2030008. doi: 10.3390/ncrna2030008. PubMed
ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer. Hoang VT, Matossian MD, Ucar DA, Elliott S, La J, Wright MK, Burks HE, Perles A, Hossain F, King CT, Browning VE, Bursavich J, Fang F, Del Valle L, Bhatt AB, Cavanaugh JE, Flaherty PT, Anbalagan M, Rowan BG, Bratton MR, Nephew KP, Miele L, Collins-Burow BM, Martin EC, Burow ME. Front Oncol. 2020 Aug 3;10:1164. doi: 10.3389/fonc.2020.01164. eCollection 2020. PubMed

If you have published an article using this material, please email us at to have your article added to this page.